Aug. 2020 | Adocia was granted a State-guaranteed loan (PGE) for EUR 7 million associated with a rescheduling of loan terms contracted with IPF Partners in 2019
Aug. 2020 | Lumeon Raises $30M in Funding to Support U.S. Growth with participation from IPF Partners
June 2020 | Poxel Announces Positive Pharmacokinetic (PK) / Pharmacodynamic (PD) Study Results for PXL770, a Direct AMPK Activator for the Treatment of NASH
June 2020 | Mainstay Medical Announces U.S. FDA Approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain
May 2020 | Poxel Announces Program Update and Preclinical Results on PXL770 for NASH Combinations and Other Metabolic Diseases
Apr. 2020 | Adocia announces positive topline results of the exploratory Phase 1b study of ADO09 (M1Pram) in people with type 1 diabetes
